Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Completed · Not applicable
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tissue and lymph node samples may help doctors identify patients with melanoma who are at risk for developing metastatic cancer. PURPOSE: This clinical trial is studying tumor tissue and lymph node samples to see how well they work in predicting the development of metastatic cancer in patients with stage I or stage II melanoma.
Key facts
- Study ID
- NCT00049010
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 314
- Starts
- 2002-09-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2016-07-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Iowa Blood and Cancer Care — Cedar Rapids, Iowa, United States
- St. Luke's Hospital — Cedar Rapids, Iowa, United States
- Mercy Regional Cancer Center at Mercy Medical Center — Cedar Rapids, Iowa, United States
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Commonwealth Hematology-Oncology P.C. - Worcester — Worcester, Massachusetts, United States
- Fairview University Medical Center - University Campus — Minneapolis, Minnesota, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia — Columbia, Missouri, United States
- Capital Region Cancer Center — Jefferson City, Missouri, United States
- Kingsbury Center for Cancer Care at Cheshire Medical Center — Keene, New Hampshire, United States
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Charles R. Wood Cancer Center at Glens Falls Hospital — Glens Falls, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- CCOP - Hematology-Oncology Associates of Central New York — Syracuse, New York, United States
- Community General Hospital of Greater Syracuse — Syracuse, New York, United States
- Wayne Memorial Hospital, Incorporated — Goldsboro, North Carolina, United States
- Wayne Radiation Oncology — Goldsboro, North Carolina, United States
- Wilson Medical Center — Wilson, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- Miriam Hospital at Lifespan — Providence, Rhode Island, United States
- Roper St. Francis Cancer Center at Roper Hospital — Charleston, South Carolina, United States
- Mountainview Medical — Berlin Corners, Vermont, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.